1. Home
  2. MLGO vs MRKR Comparison

MLGO vs MRKR Comparison

Compare MLGO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLGO
  • MRKR
  • Stock Information
  • Founded
  • MLGO 2018
  • MRKR N/A
  • Country
  • MLGO China
  • MRKR United States
  • Employees
  • MLGO N/A
  • MRKR N/A
  • Industry
  • MLGO EDP Services
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLGO Technology
  • MRKR Health Care
  • Exchange
  • MLGO Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • MLGO 36.6M
  • MRKR 30.7M
  • IPO Year
  • MLGO N/A
  • MRKR N/A
  • Fundamental
  • Price
  • MLGO $1.89
  • MRKR $3.95
  • Analyst Decision
  • MLGO
  • MRKR Strong Buy
  • Analyst Count
  • MLGO 0
  • MRKR 1
  • Target Price
  • MLGO N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • MLGO 16.0M
  • MRKR 91.1K
  • Earning Date
  • MLGO 02-03-2025
  • MRKR 11-14-2024
  • Dividend Yield
  • MLGO N/A
  • MRKR N/A
  • EPS Growth
  • MLGO N/A
  • MRKR N/A
  • EPS
  • MLGO N/A
  • MRKR N/A
  • Revenue
  • MLGO $83,504,125.00
  • MRKR $5,395,849.00
  • Revenue This Year
  • MLGO N/A
  • MRKR $35.94
  • Revenue Next Year
  • MLGO N/A
  • MRKR N/A
  • P/E Ratio
  • MLGO N/A
  • MRKR N/A
  • Revenue Growth
  • MLGO 643.57
  • MRKR 79.04
  • 52 Week Low
  • MLGO $1.75
  • MRKR $2.44
  • 52 Week High
  • MLGO $509.60
  • MRKR $6.16
  • Technical
  • Relative Strength Index (RSI)
  • MLGO 30.17
  • MRKR 50.16
  • Support Level
  • MLGO $1.77
  • MRKR $3.47
  • Resistance Level
  • MLGO $2.21
  • MRKR $5.95
  • Average True Range (ATR)
  • MLGO 0.44
  • MRKR 0.63
  • MACD
  • MLGO -0.06
  • MRKR 0.01
  • Stochastic Oscillator
  • MLGO 6.16
  • MRKR 16.99

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: